On October 31, 2022, William F. Ciambrone informed Sarepta Therapeutics, Inc. (the Company) of his resignation from his position as the Company's Executive Vice President, Technical Operations, effective as of December 31, 2022. On October 31, 2022, the Board appointed Bilal Arif, the Company's Senior Vice President, Strategy and Operations, as the Company's Chief Technical Operations Officer, effective as of December 31, 2022 and upon Mr. Ciambrone's retirement.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
129.8 USD | +4.28% | +5.12% | +34.58% |
30/05 | Sector Update: Health Care Stocks Mixed Pre-Bell Thursday | MT |
30/05 | Sector Update: Health Care | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.58% | 12.27B | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- SRPT Stock
- News Sarepta Therapeutics, Inc.
- Sarepta Therapeutics, Inc. Announces Executive Changes